Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Marie Beguinot"'
Autor:
Marie Beguinot, Marie-Melanie Dauplat, Fabrice Kwiatkowski, Guillaume Lebouedec, Lucie Tixier, Christophe Pomel, Frederique Penault-Llorca, Nina Radosevic-Robin
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-10 (2018)
Abstract Background Tumour-infiltrating lymphocytes (TILs) have been demonstrated to significantly influence prognosis and response to therapy of invasive breast cancer (IBC). Thus, it has been suggested that TIL density or/and immunophenotype could
Externí odkaz:
https://doaj.org/article/c5ad628c979a4b1d90f99da8187ad503
Publikováno v:
Sages-Femmes. 20:14-17
Au moment de l’annonce d’un cancer, trois patientes sur quatre âgees de 18 a 45 ans sont concernees par un desir de grossesse. Les consequences des traitements anticancereux sur la fertilite doivent etre discutees des le diagnostic, afin d’ori
Autor:
Angeline Ginzac, Guillaume Gayraud, Pierre Gimbergues, Emilie Monrigal, Marie Beguinot, Dominique Joly, Fabrice Kwiatkowski, Guillaume Le Bouedec
Publikováno v:
Journal of Surgical Research
Journal of Surgical Research, Elsevier, 2020, 254, pp.318-326. ⟨10.1016/j.jss.2020.05.006⟩
Journal of Surgical Research, Elsevier, 2020, 254, pp.318-326. ⟨10.1016/j.jss.2020.05.006⟩
Background To evaluate the efficacy of continuous wound infiltration with ropivacaine to reduce acute postoperative pain in patients undergoing mastectomy for carcinoma of the breast. Materials and methods A randomized, double-blind, placebo-controll
Publikováno v:
Surgical Oncology. 34:103-108
Background Before radical mastectomy with immediate latissimus dorsi flap reconstruction, single-shot paravertebral block (PVB) can be added to general anesthesia to improve analgesia. As this technique was introduced in 2014 in our centre, our aim w
Publikováno v:
EMC - Ginecología-Obstetricia. 56:1-8
Resumen El cancer de ovario es la quinta causa mas frecuente de muerte por cancer en la mujer. Su descubrimiento se realiza en un estadio avanzado y la recidiva es, por desgracia, frecuente (cerca del 70% de los casos). El tratamiento inicial y en la
Publikováno v:
Médecine Palliative. 18:313-317
Resume Introduction La nutrition artificielle en fin de vie est un sujet complexe. Elle amene souvent de nombreux questionnements, car elle est liee a de nombreux symboles se rapportant a la societe, l’ethique, les soins et bien d’autres. Materie
Publikováno v:
Vocation Sage-femme. 18:33-36
Autor:
P F Montoriol, Cherrif Akladios, Fabrice Lecuru, Christophe Pomel, Michel Canis, Emilie Thivat, Gwennael Ferron, Arnaud Wattiez, Roman Rouzier, Jean-Marc Classe, Nicolas Paillocher, Virginie Fourchotte, Eric Lambaudie, Marie Beguinot
Publikováno v:
International Journal of Gynecological Cancer
International Journal of Gynecological Cancer, 2021, 31 (12), pp.1. ⟨10.1136/ijgc-2021-002888⟩
International Journal of Gynecological Cancer, 2021, 31 (12), pp.1. ⟨10.1136/ijgc-2021-002888⟩
ObjectiveThe aim of this study was to explore the feasibility and safety of the laparoscopic approach after neoadjuvant chemotherapy among selected chemosensitive patients with advanced ovarian cancer.MethodsThe CILOVE study was a phase II prospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a6a7f11dd291f17c81f72dbb9939640d
https://hal.uca.fr/hal-03690312
https://hal.uca.fr/hal-03690312
Autor:
Caroline Cornou, Guillaume Le Bouedec, Frédérique Penault-Llorca, Marie Beguinot, Christophe Pomel, Frédéric Selle, Léonie Picard, Marie-Ange Mouret-Reynier, Charlotte Bourgin
Publikováno v:
Bulletin du Cancer
Bulletin du Cancer, John Libbey Eurotext, 2019, ⟨10.1016/j.bulcan.2019.04.003⟩
Bulletin du Cancer, John Libbey Eurotext, 2019, ⟨10.1016/j.bulcan.2019.04.003⟩
The results of PRODIGE 7 study demonstrate that the use of HIPEC is not beneficial for patients in the treatment of colorectal carcinomatosis. Nevertheless, a recent study published in NewEnglandJournalofMedicine showed that hyperthermic intraperiton
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2452b74773e1110f6771a1e41277c50d
https://hal.archives-ouvertes.fr/hal-02343537/file/S0007455119301936.pdf
https://hal.archives-ouvertes.fr/hal-02343537/file/S0007455119301936.pdf
Autor:
Anne-Sophie Grémeau, Charlotte Chaptal, Marie Beguinot, Céline Verlet, Mathilde Gay-Bellile, Sylvie Jouvency, Claire Laquet, Pascal Dessenne, Yves-Jean Bignon, Marilyn Broult, Marie-Françoise Petit, Fabrice Kwiatkowski, Véronique Boussion, Martine Duclos
Publikováno v:
Hereditary Cancer in Clinical Practice
Hereditary Cancer in Clinical Practice, BioMed Central, 2019, 17, ⟨10.1186/s13053-019-0107-7⟩
Hereditary Cancer in Clinical Practice, 2019, 17, ⟨10.1186/s13053-019-0107-7⟩
Hereditary Cancer in Clinical Practice (17), . (2019)
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-9 (2019)
Hereditary Cancer in Clinical Practice, BioMed Central, 2019, 17, ⟨10.1186/s13053-019-0107-7⟩
Hereditary Cancer in Clinical Practice, 2019, 17, ⟨10.1186/s13053-019-0107-7⟩
Hereditary Cancer in Clinical Practice (17), . (2019)
Hereditary Cancer in Clinical Practice, Vol 17, Iss 1, Pp 1-9 (2019)
Background In families with high risk of hereditary breast/ovarian cancer (HBOC), women before age 30 do not yet undergo clinical screening, but they are exposed to contradictory information from diverse sources. They may be presented with surgical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fc3946871ba1f9b8012c6cee1d9c7dc
https://hal.archives-ouvertes.fr/hal-02076059/document
https://hal.archives-ouvertes.fr/hal-02076059/document